Another key finding of our study is that Tyk2-/- and Tyk2K923E mice show a similar reduction in C. albicans invasion into the deep skin and dissemination to kidneys when compared to wild-type controls, suggesting that TYK2 kinase inhibition might be an option to treat cutaneous candidiasis. The gene discussed is TYK2; the disease is cutaneous candidiasis.